You are here: Welcome » Philippe De Wals

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
philippe_de_wals [2022/04/21 09:37]
liam [Research] 		philippe_de_wals [2022/04/21 10:10] (current)
liam [Research]
Line 46: Line 46:
  
 Additional funding has come from the [[Public Health Agency of Canada]] and the [[Quebec Ministry of Health and Social Services]].((Cléophat, J.-E., Le Meur, J.-B., Proulx, J.-F., & De Wals, P. (2014). //Uptake of pneumococcal vaccines in the Nordic region of Nunavik, province of Quebec, Canada.// Canadian Journal of Public Health, 105(4), e268–e272. https://doi.org/10.17269/cjph.105.4315)) Additional funding has come from the [[Public Health Agency of Canada]] and the [[Quebec Ministry of Health and Social Services]].((Cléophat, J.-E., Le Meur, J.-B., Proulx, J.-F., & De Wals, P. (2014). //Uptake of pneumococcal vaccines in the Nordic region of Nunavik, province of Quebec, Canada.// Canadian Journal of Public Health, 105(4), e268–e272. https://doi.org/10.17269/cjph.105.4315))
 +
 +In 2021, De Wals participated in the The Pneumococcal Serotype Replacement and Distribution Estimation ([[PSERENADE]]) Project, funded by the [[Bill & Melinda Gates Foundation]] as part of the [[World Health Organization]] [[Pneumococcal Vaccines Technical Coordination Project]].((Deloria Knoll, M., Bennett, J., Garcia Quesada, M., Kagucia, E., Peterson, M., Feikin, D., Cohen, A., Hetrich, M., Yang, Y., Sinkevitch, J., Ampofo, K., Aukes, L., Bacci, S., Bigogo, G., Brandileone, M.-C., Bruce, M., Camilli, R., Castilla, J., Chan, G., & Chanto Chacón, G. (2021). //Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.// Microorganisms, 9(4), 742. https://doi.org/10.3390/microorganisms9040742))
Back to top